Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after it reported its third quarter earnings report. The company saw its net income rise 7% in the quarter, citing the growth of Cosentyx, its psoriasis treatment, as well as its eye care business and some cancer drugs. For the period, … Continue reading “Novartis Climbs Higher After Earnings Rise”
